Organovo Holdings Files Routine 8-K, Confirms Nasdaq Listing

TL;DR

**ONVO filed a routine 8-K, no major news, just confirming its Nasdaq listing.**

AI Summary

Organovo Holdings, Inc. (ONVO) filed an 8-K on February 7, 2024, to disclose general corporate information and confirm its status as a publicly traded company on The Nasdaq Stock Market LLC under the trading symbol ONVO. This filing primarily serves to update administrative details and reaffirm its compliance with SEC regulations, rather than announcing a specific material event. For investors, this filing is a routine update, indicating no immediate significant changes to the company's operations or financial standing, which might suggest a period of stability or lack of new developments.

Why It Matters

This filing is a standard administrative update, confirming Organovo's continued listing on Nasdaq and compliance with SEC regulations, which is important for maintaining investor confidence and market access.

Risk Assessment

Risk Level: low — This 8-K is a routine administrative filing with no new material information that would introduce significant risk.

Analyst Insight

A smart investor would view this as a non-event, confirming the company's administrative compliance but providing no new information to alter investment decisions. It suggests a period of operational normalcy.

Key Numbers

• 001-35996 — Commission File Number (Identifies Organovo's registration with the SEC.)
• 27-1488943 — IRS Employer Identification No. (Standard identification for tax purposes.)
• February 07, 2024 — Date of Report (Indicates the filing date and earliest event reported.)
• $0.001 — par value per share (The nominal value of Organovo's common stock.)

Key Players & Entities

• Organovo Holdings, Inc. (company) — the registrant filing the 8-K
• ONVO (company) — the trading symbol for Organovo Holdings, Inc.
• The Nasdaq Stock Market LLC (company) — the exchange where Organovo's common stock is registered
• February 07, 2024 (date) — the date of the earliest event reported and filing date
• Delaware (company) — state of incorporation for Organovo Holdings, Inc.
• 001-35996 (dollar_amount) — Commission File Number
• 27-1488943 (dollar_amount) — IRS Employer Identification No.
• 11555 Sorrento Valley Rd Suite 100, San Diego, California, 92121 (company) — Address of Principal Executive Offices
• (858) 224-1000 (dollar_amount) — Registrant's Telephone Number

Forward-Looking Statements

• Organovo Holdings, Inc. will continue to maintain its listing on The Nasdaq Stock Market LLC. (Organovo Holdings, Inc.) — high confidence, target: 2025-02-07
• No significant corporate actions (e.g., mergers, major acquisitions, significant financial distress) will be announced in the immediate future based on this routine filing. (Organovo Holdings, Inc.) — medium confidence, target: 2024-05-07

FAQ

Key Financial Figures

• $0.001 — nge on which registered Common Stock, $0.001 par value ONVO The Nasdaq Stock Mar

Filing Documents

• onvo-20240207.htm (8-K) — 42KB
• onvo-ex99_1.htm (EX-99.1) — 11KB
• onvo-ex99_1s1.jpg (GRAPHIC) — 414KB
• onvo-ex99_1s2.jpg (GRAPHIC) — 1002KB
• onvo-ex99_1s3.jpg (GRAPHIC) — 496KB
• onvo-ex99_1s4.jpg (GRAPHIC) — 564KB
• onvo-ex99_1s5.jpg (GRAPHIC) — 464KB
• onvo-ex99_1s6.jpg (GRAPHIC) — 419KB
• onvo-ex99_1s7.jpg (GRAPHIC) — 576KB
• onvo-ex99_1s8.jpg (GRAPHIC) — 346KB
• onvo-ex99_1s9.jpg (GRAPHIC) — 544KB
• onvo-ex99_1s10.jpg (GRAPHIC) — 509KB
• onvo-ex99_1s11.jpg (GRAPHIC) — 380KB
• onvo-ex99_1s12.jpg (GRAPHIC) — 434KB
• onvo-ex99_1s13.jpg (GRAPHIC) — 474KB
• 0000950170-24-011954.txt ( ) — 9286KB
• onvo-20240207.xsd (EX-101.SCH) — 24KB
• onvo-20240207_htm.xml (XML) — 5KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. Organovo Holdings, Inc. (the "Company") is furnishing a corporate presentation, attached as Exhibit 99.1 to this Current Report on Form 8-K (the "Corporate Presentation"), which the Company intends to post on the Company's website. The Corporate Presentation was presented at the Crohn's & Colitis Congress in January 2024. The Corporate Presentation is current as of January 25, 2024, and the Company disclaims any obligation to update this material in the future. The information in this Item 7.01, including the Corporate Presentation attached hereto as Exhibit 99.1, is being furnished under Item 7.01 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and it shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits (d) Exhibits. Number Description 99.1 Corporate Presentation, dated January 25, 2024 104 Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL). * * *

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Organovo Holdings, Inc. Date: February 7, 2024 By: /s/ Keith Murphy Name: Keith Murphy Title: Executive Chairman

View Full Filing

View this 8-K filing on SEC EDGAR